SpringWorks Therapeutics, Inc.

SWTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$258-$325-$277-$174
Dep. & Amort.$3$2$1$0
Deferred Tax$0$0$0$1
Stock-Based Comp.$109$95$73$38
Change in WC-$38-$1$38$5
Other Non-Cash$8$7$4$1
Operating Cash Flow-$176-$223-$162-$128
Investing Activities
PP&E Inv.-$4-$7-$10-$2
Net Acquisitions-$8-$3-$4$2
Inv. Purchases-$285-$576-$481-$305
Inv. Sales/Matur.$379$621$280$391
Other Inv. Act.-$16$0$0-$2
Investing Cash Flow$65$35-$216$84
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$13$299$340$1
Stock Repurch.-$8-$3-$1$0
Dividends Paid$0$0$0$0
Other Fin. Act.$13$0$2$1
Financing Cash Flow$5$297$341$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$106$109-$36-$43
Supplemental Information
Beg. Cash$177$68$105$148
End Cash$70$177$68$105
Free Cash Flow-$180-$230-$172-$130